Disease Domain | Count |
---|---|
Nervous System Diseases | 2 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 2 |
Top 5 Target | Count |
---|---|
NET(Norepinephrine transporter) | 2 |
Target |
Mechanism NET inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism NET inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism HDAC inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
WY-46824 ( NET ) | Depressive Disorder More | Preclinical |
WAY-256805 ( NET ) | Pain More | Preclinical |
EVP-0334 ( HDACs ) | Alzheimer Disease More | Discontinued |